Importer of Controlled Substances Application: VHG Labs DBA LGC Standards, 21888-21889 [2020-08328]
Download as PDF
<![CDATA[
21888
Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices
Controlled substance
Drug code
Dihydrocodeine ................................................................................................................................................................
Difenoxin ..........................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
The company plans to import the bulk
control substances for distribution of
analytical reference standards to its
customers for analytical testing of raw
materials.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–08269 Filed 4–17–20; 8:45 am]
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 20, 2020. Such persons
may also file a written request for a
hearing on the application on or before
May 20, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
ADDRESSES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–624]
Importer of Controlled Substances
Application: VHG Labs DBA LGC
Standards
ACTION:
Notice of application.
In
accordance with 21 CFR 1301.34(a), this
is notice that on March 12, 2020, VHG
Labs DBA LGC Standards, 3 Perimeter
Road, Manchester, New Hampshire
03103, applied to be registered as an
importer of the following basic class(es)
of controlled substances:
SUPPLEMENTARY INFORMATION:
jbell on DSKJLSW7X2PROD with NOTICES
Drug code
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Naphyrone .......................................................................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ..............................................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..................................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ....................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .....................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ......................................................................................................
Ibogaine ...........................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Marihuana Extract ...........................................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Mescaline .........................................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ......................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Psilocyn ...........................................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .....................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Butylone ...........................................................................................................................................................................
Pentylone .........................................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
18:34 Apr 17, 2020
Jkt 250001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
II
I
II
I
II
II
II
II
I
II
I
II
II
II
II
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Controlled substance
VerDate Sep<11>2014
9120
9168
9170
9200
9210
9220
9230
9273
9307
9333
9634
9652
9668
9737
9740
Schedule
E:\FR\FM\20APN1.SGM
20APN1
1235
1237
1258
1475
6250
7008
7048
7081
7104
7118
7122
7144
7203
7260
7315
7350
7360
7370
7381
7398
7405
7431
7438
7498
7535
7540
7541
7542
9053
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
21889
Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices
Controlled substance
Drug code
Desomorphine .................................................................................................................................................................
Dihydromorphine .............................................................................................................................................................
Heroin ..............................................................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Normorphine ....................................................................................................................................................................
Tilidine .............................................................................................................................................................................
Alpha-methylfentanyl .......................................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
Methamphetamine ...........................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Phenylacetone .................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Meperidine intermediate-C ..............................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
14-Hydroxmorphone ........................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis. In reference to drug codes 7360
(Marihuana) and 7370
(Tetrahydrocannabinols) the company
plans to import a synthetic cannabidiol
and a synthetic tetrahydrocannabinols.
No other activities for these drug codes
are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–08328 Filed 4–17–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–621]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Groff NA
Hemplex LLC
jbell on DSKJLSW7X2PROD with NOTICES
ACTION:
Notice of application.
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
SUMMARY:
VerDate Sep<11>2014
18:34 Apr 17, 2020
Jkt 250001
pending applications according to
proposed regulations that, if finalized,
would govern the program of growing
marihuana for scientific and medical
research under DEA registration.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 19, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket No.
DEA–621 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
9055
9145
9200
9307
9313
9750
9814
9821
1105
1631
1724
2125
2270
2315
2550
7471
8501
9050
9120
9170
9180
9190
9193
9220
9230
9233
9234
9273
9665
9668
9740
9801
Schedule
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA-registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA
proposes to conduct this evaluation in
the manner described in the rule
proposed at 85 FR 16292, published on
March 23, 2020, if finalized.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on February 28, 2020, Groff NA
Hemplex LLC, 100 Redco Avenue, Suite
E:\FR\FM\20APN1.SGM
20APN1
]]>Agencies
[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Pages 21888-21889]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08328]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-624]
Importer of Controlled Substances Application: VHG Labs DBA LGC
Standards
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before May 20, 2020.
Such persons may also file a written request for a hearing on the
application on or before May 20, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 12, 2020, VHG Labs DBA LGC Standards, 3
Perimeter Road, Manchester, New Hampshire 03103, applied to be
registered as an importer of the following basic class(es) of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................ 1235 I
Methcathinone............................ 1237 I
Naphyrone................................ 1258 I
N-Ethylamphetamine....................... 1475 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide.
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I
[(4-methoxy)-benzoyl] indole.
JWH-018 (also known as AM678) (1-Pentyl-3- 7118 I
(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
Ibogaine................................. 7260 I
Lysergic acid diethylamide............... 7315 I
Marihuana Extract........................ 7350 I
Marihuana................................ 7360 I
Tetrahydrocannabinols.................... 7370 I
Mescaline................................ 7381 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
3,4-Methylenedioxymethamphetamine........ 7405 I
5-Methoxy-N-N-dimethyltryptamine......... 7431 I
Psilocyn................................. 7438 I
4-Methyl-alphapyrrolidinopropiophenone (4- 7498 I
MePPP).
MDPV (3,4-Methylenedioxypyrovalerone).... 7535 I
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone................................. 7541 I
Pentylone................................ 7542 I
Codeine-N-oxide.......................... 9053 I
[[Page 21889]]
Desomorphine............................. 9055 I
Dihydromorphine.......................... 9145 I
Heroin................................... 9200 I
Morphine-N-oxide......................... 9307 I
Normorphine.............................. 9313 I
Tilidine................................. 9750 I
Alpha-methylfentanyl..................... 9814 I
Acetyl Fentanyl (N-(1-phenethylpiperidin- 9821 I
4-yl)-N-phenylacetamide).
Methamphetamine.......................... 1105 II
Phenmetrazine............................ 1631 II
Methylphenidate.......................... 1724 II
Amobarbital.............................. 2125 II
Pentobarbital............................ 2270 II
Secobarbital............................. 2315 II
Glutethimide............................. 2550 II
Phencyclidine............................ 7471 II
Phenylacetone............................ 8501 II
Codeine.................................. 9050 II
Dihydrocodeine........................... 9120 II
Diphenoxylate............................ 9170 II
Ecgonine................................. 9180 II
Ethylmorphine............................ 9190 II
Hydrocodone.............................. 9193 II
Levorphanol.............................. 9220 II
Meperidine............................... 9230 II
Meperidine intermediate-B................ 9233 II
Meperidine intermediate-C................ 9234 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
14-Hydroxmorphone........................ 9665 II
Noroxymorphone........................... 9668 II
Sufentanil............................... 9740 II
Fentanyl................................. 9801 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
sale to research facilities for drug testing and analysis. In reference
to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the
company plans to import a synthetic cannabidiol and a synthetic
tetrahydrocannabinols. No other activities for these drug codes are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08328 Filed 4-17-20; 8:45 am]
BILLING CODE 4410-09-P
